Genmab A/S Research and Development Expense
Genmab A/S (GMAB) reported Research and Development Expense of $1.61 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-02-17
- Genmab A/S research and development expense for the quarter ending 2024-06-30 was 2.50B DKK, a 35.02% increase year-over-year.
- Genmab A/S research and development expense for the quarter ending 2023-06-30 was 1.85B DKK, a 44.54% increase year-over-year.
- Genmab A/S research and development expense for the quarter ending 2022-06-30 was 1.28B DKK, a 39.20% increase year-over-year.
- Genmab A/S research and development expense for the quarter ending 2021-06-30 was 921.00M DKK, a 18.84% increase year-over-year.
DKK
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | 9.75B DKK 6-K · filed 2025-02-12 | ||||
| 2024-06-30 | 2.50B DKK 6-K · filed 2024-08-08 | 4.80B DKK 6-K · filed 2024-08-08 | |||
| 2023-12-31 | 7.63B DKK 6-K · filed 2025-02-12 | ||||
| 2023-06-30 | 1.85B DKK 6-K · filed 2024-08-08 | 3.59B DKK 6-K · filed 2024-08-08 | |||
| 2022-12-31 | 5.56B DKK 6-K · filed 2025-02-12 | ||||
| 2022-06-30 | 1.28B DKK 6-K · filed 2023-08-03 | 2.44B DKK 6-K · filed 2023-08-03 | |||
| 2021-12-31 | 4.18B DKK 6-K · filed 2024-02-14 | ||||
| 2021-06-30 | 921.00M DKK 6-K · filed 2022-08-10 | 1.77B DKK 6-K · filed 2022-08-10 | |||
| 2020-12-31 | 3.14B DKK 6-K · filed 2023-02-22 | ||||
| 2020-06-30 | 775.00M DKK 6-K · filed 2021-08-11 | 1.49B DKK 6-K · filed 2021-08-11 | |||
| 2019-12-31 | 2.39B DKK 6-K · filed 2022-02-16 | ||||
| 2019-06-30 | 564.00M DKK 6-K · filed 2020-08-12 | 563.38M DKK 6-K · filed 2019-08-14 | 1.11B DKK 6-K · filed 2020-08-12 | 1.11B DKK 6-K · filed 2019-08-14 | |
| 2018-12-31 | 1.43B DKK 6-K · filed 2021-02-23 | ||||
| 2018-06-30 | 318.89M DKK 6-K · filed 2019-08-14 | 631.44M DKK 6-K · filed 2019-08-14 | |||
| 2017-12-31 | 874.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $1.61B 20-F · filed 2026-02-17 | ||
| 2025-06-30 | $364.00M 6-K · filed 2025-08-07 | $723.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $1.41B 20-F · filed 2026-02-17 | ||
| 2024-06-30 | $361.00M 6-K · filed 2025-08-07 | $696.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $1.11B 20-F · filed 2026-02-17 |